J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio

KEY TAKEAWAYS Johnson & Johnson said it would pay $13.1 billion to buy cardiovascular catheter maker Shockwave Medical as it boosts its heart treatment portfolio.The purchase price of $335 per share was a 4.7% premium to Shockwave's closing price yesterday.J&J said the acquisition increases its strength in the fast-growing cardiovascular intervention market. Johnson & Johnson (JNJ) announced Friday it was buying Shockwave Medical (SWAV) for $13.1 billion in cash, pushing shares of the maker of cardiovascula ...